Back
LHA Market State Tactical Beta ETF Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
63
MSTB
LHA Market State Tactical Beta ETF
Last Price:
$40.05
Seasonality Move:
-1.31%
Buy
87
KYMR
Kymera Therapeutics, Inc.
Last Price:
$89.98
Seasonality Move:
7.7%
Buy
63
LHA Market State Tactical Beta ETF (MSTB)
is a Buy
Is LHA Market State Tactical Beta ETF a Buy, Sell or Hold?
-
The current LHA Market State Tactical Beta ETF [MSTB] share price is $40.01. The Score for MSTB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
MSTB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
MSTB Stock Price Chart
What is LHA Market State Tactical Beta ETF's stock price today?
-
The LHA Market State Tactical Beta ETF share price today is $40.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSTB is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $86.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
MSTB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 51.03 | Buy |
| Chaikin Money Flow: | 24277 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.5 - 40.4) | Buy |
| Bollinger Bands (100): | (38.31 - 40.23) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.97 | Buy |
| Relative Strength Index (14 RSI): | 72.81 | Buy |
| Chaikin Money Flow: | -897315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.72 - 73.96) | Buy |
| Bollinger Bands (100): | (43.27 - 64.19) | Buy |
MSTB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.03 | Sell |
| 20-day SMA: | 39.87 | Buy |
| 50-day SMA: | 40.07 | Sell |
| 200-day SMA: | 37.01 | Buy |
| 8-day EMA: | 39.99 | Buy |
| 20-day EMA: | 39.96 | Buy |
| 50-day EMA: | 38.92 | Buy |
| 200-day EMA: | 23.95 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.38 | Buy |
| 20-day SMA: | 67.89 | Buy |
| 50-day SMA: | 62.54 | Buy |
| 200-day SMA: | 44.51 | Buy |
| 8-day EMA: | 75.59 | Buy |
| 20-day EMA: | 69.41 | Buy |
| 50-day EMA: | 62.91 | Buy |
| 200-day EMA: | 49.79 | Buy |
LHA Market State Tactical Beta ETF Earnings Growth & MSTB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.
LHA Market State Tactical Beta ETF Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||